Total | 21 | 44 | | | |
Sex (Male : Female) | 9 : 11 | 20 : 25 | 0.97 | | |
Age | 47.40 ±16.6 | 53.8±17.0 | 0.163 | | |
Underlying disease | | | | | |
HTN | 6 (30.0%) | 19 (42.2%) | 0.35 | | |
DM | 2 (10.0%) | 13 (28.9%) | 0.12 | | |
CVD | 3 (15.0%) | 6 (13.3%) | 1.00 | | |
Vertigo | 6 (30.0%) | 28 (62.2%) | 0.016 | −0.206 | 0.088 |
Onset to treatment (day) | 3.1 ± 295 | 3.8±4.6 | 0.491 | | |
Initial audio threshold (dB) | 97.0±6.9 | 105.2±9.6 | 0.000 | −2.847 | 0.006 |
Abnormal caloric | 6 (30.0%) | 16 (35.6%) | 0.662 | | |
Canal paresis of caloric test (%) | 18.2 ± 15.4 | 26.1 ± 25.4 | 0.203 | | |
Abnormal cVEMP | 11 (55.5%) | 26 (57.8%) | 0.604 | | |
Video Head impulse test | | | | | |
Lateral canal gain (> 0.7) | 0 | 3 | 0.553 | | |
Gain of affected side (Lat.) | 1.06 ±0.11 | 0.99 ±0.29 | 0.535 | | |
Anterior canal gain (>0.7) | 3 | 11 | 0.704 | | |
Gain of affected side (Ant.) | 0.81 ± 0.24 | 0.67± 0.30 | 0.207 | | |
Posterior canal gain (>0.7) | 1 | 9 | 0.217 | | |
Gain of affected side (Post.) | 1.01 ± 0.24 | 0.89 ±0.28 | 0.283 | | |